January 27, 2021 Life Science Tools PR/Corporate

Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020... Read more

January 26, 2021 Life Science Tools PR/Corporate

BD Names CEO Tom Polen as Chairman of the Board

Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021. Polen will succeed Vincent A. Forlenza, who... Read more

January 26, 2021 Life Science Tools Liq. Handling & Robotics M&A, Partnerships

SPT Labtech Announces a Co-Marketing Initiative with Thermo Fisher Scientific to Help Reduce the Cost of NGS Library Prep

Initiative to promote the benefit of using Thermo Fisher Scientific’s library prep kits with SPT Labtech’s instruments to help reduce reagent and material requirements for high-throughput genome sequencing  To download this image, please click here.  Cambridge, UK – January 26 2021 – The cost of library preparation is one of the biggest obstacles to large next-generation sequencing (NGS) studies,... Read more

January 26, 2021 Clinical Research/Diagn. Life Science Tools Product Launch

PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings extend the... Read more

January 26, 2021 Clinical Research/Diagn. Life Science Tools Product Launch

LGC launches SARS-CoV-2 molecular solution for Oral Fluid Testing

LGC has expanded its innovative portfolio of SARS-CoV-2 quality solutions with the release of AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid reference material. The product is designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics.  It serves as an ideal research tool for assay developers as well as a complete quality solution for clinical laboratories... Read more

January 26, 2021 Chemicals, Reagents & Kits Clinical Research/Diagn. Lab Top-10 Life Science Tools Product Launch

PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR      (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings... Read more

January 21, 2021 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Fluidigm Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19

Jan 21, 2021 SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company has received the CE-IVD mark for its Advanta™ Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.... Read more

January 21, 2021 Chemicals, Reagents & Kits Clinical Research/Diagn. Life Science Tools

Sales of Novel Coronavirus PCR Testing Reagent Kits outside Japan Exports Began

January 21, 2021 Shimadzu Corporation will begin fully rolling out sales of the novel coronavirus (SARS-CoV-2) detection reagent kits outside Japan. On January 19th, Shimadzu obtained provisional authorization from the Singapore Health Sciences Authority (HSA) to sell the kits and will start exporting the kits to Southeast Asian markets through Shimadzu (Asia Pacific) Pte. Ltd.,... Read more

January 20, 2021 Life Science Tools PAI Top-10

QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus

Germantown, Maryland, and Hilden, Germany, January 20, 2021 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections – and will continue to closely monitor their performance as global concerns mount regarding the detection of new viral variants by established... Read more